Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-11-28
pubmed:abstractText
To assess the long-term safety (primary aim) and efficacy (secondary aim) of the MAO-B inhibitor Selegiline Transdermal System (STS) for the treatment of HIV-associated cognitive impairment.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/2 U01 NS0322228-08A1, http://linkedlifedata.com/resource/pubmed/grant/5-M01-RR-00722, http://linkedlifedata.com/resource/pubmed/grant/AA69495, http://linkedlifedata.com/resource/pubmed/grant/AI038855, http://linkedlifedata.com/resource/pubmed/grant/AI06863, http://linkedlifedata.com/resource/pubmed/grant/AI068634, http://linkedlifedata.com/resource/pubmed/grant/AI25903, http://linkedlifedata.com/resource/pubmed/grant/AI25915, http://linkedlifedata.com/resource/pubmed/grant/AI27658, http://linkedlifedata.com/resource/pubmed/grant/AI27659, http://linkedlifedata.com/resource/pubmed/grant/AI27660, http://linkedlifedata.com/resource/pubmed/grant/AI27664, http://linkedlifedata.com/resource/pubmed/grant/AI27668, http://linkedlifedata.com/resource/pubmed/grant/AI27670, http://linkedlifedata.com/resource/pubmed/grant/AI34853, http://linkedlifedata.com/resource/pubmed/grant/AI38858, http://linkedlifedata.com/resource/pubmed/grant/AI46370, http://linkedlifedata.com/resource/pubmed/grant/AI46376, http://linkedlifedata.com/resource/pubmed/grant/AI46381, http://linkedlifedata.com/resource/pubmed/grant/AI46386, http://linkedlifedata.com/resource/pubmed/grant/AI69423, http://linkedlifedata.com/resource/pubmed/grant/AI69424, http://linkedlifedata.com/resource/pubmed/grant/AI69432, http://linkedlifedata.com/resource/pubmed/grant/AI69434, http://linkedlifedata.com/resource/pubmed/grant/AI69465, http://linkedlifedata.com/resource/pubmed/grant/AI69467, http://linkedlifedata.com/resource/pubmed/grant/AI69470, http://linkedlifedata.com/resource/pubmed/grant/AI69471, http://linkedlifedata.com/resource/pubmed/grant/AI69472, http://linkedlifedata.com/resource/pubmed/grant/AI69494, http://linkedlifedata.com/resource/pubmed/grant/AI69495, http://linkedlifedata.com/resource/pubmed/grant/AI69511, http://linkedlifedata.com/resource/pubmed/grant/MH64409, http://linkedlifedata.com/resource/pubmed/grant/RR00044, http://linkedlifedata.com/resource/pubmed/grant/U01-AI-35040, http://linkedlifedata.com/resource/pubmed/grant/U01-AI-35041, http://linkedlifedata.com/resource/pubmed/grant/U01-AI-35042, http://linkedlifedata.com/resource/pubmed/grant/U01-AI-35043, http://linkedlifedata.com/resource/pubmed/grant/U01-AI-37613, http://linkedlifedata.com/resource/pubmed/grant/U01-AI-37984
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1528-4336
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
437-46
pubmed:meshHeading
pubmed:articleTitle
Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090.
pubmed:affiliation
Harvard School of Public Health, Boston, Massachusetts, USA.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II, Research Support, N.I.H., Extramural